USPTO serial 79236843
ALTONA
Reviewed by CopyMark Law Group
Reg. 6121013Status 706Renewal
- Filing date
- Status date
- Registration date
- Aug 11, 2020
- Examiner
- LAMONT, MIAH ROSENBERG
- Law office
- Historical data usage
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with ALTONA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,046*
Plus Government fees of $1,700
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Matthew J. Smith
Matthew J. Smith Polsinelli PCPO Box 140310Kansas City, MO 64114-0310United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biological preparations for use in sample preparation and pathogen detection other than for medical or veterinary use, namely, biological preparations for use in industry, private and/or federal laboratories and/or science; biological substances and chemical preparations, namely, reagents for isolation and purification of nucleic acids, in vitro diagnostic test reagents, and control standards for scientific and research purposes; diagnostic reagents for use in identifying pathogens for scientific and research use; diagnostic kits consisting primarily of diagnostic reagents for use in identifying pathogens for scientific and research use; chemical substances for analysis in scientific and laboratory research, other than for medical or veterinary purposes; chemicals for use in industry | ACTIVE | — |
| 005 | Pharmaceutical and veterinary preparations, namely, biological substances and chemical preparations used for medical purposes, namely, diagnosing and monitoring infectious diseases; in vitro diagnostic preparations for medical purposes; in vitro diagnostic test reagents and control standards, namely, reference standards in the nature of pure materials being synthetic DNA, all for medical diagnostic use or veterinary use; diagnostic preparations for medical use; diagnostic reagents for use in identifying pathogens for medical use; diagnostic kits consisting primarily of diagnostic reagents for use in identifying pathogens for medical use; biological preparations for the treatment of cancer; chemical preparation for the diagnosis of pregnancy | ACTIVE | — |
| 009 | Scientific apparatus and instruments for laboratory use and for the conducting and evaluation of diagnostic examinations, namely, fluid handling devices used for disposable bioprocessing applications, pipette racks for laboratory use, sensing and signaling devices for measurement and quality control of materials processing by laser; medical laboratory research instruments for DNA analysis and RNA analysis; computers; data processing apparatus and structural and replacement parts thereof; data processors; computer software programs for controlling laboratory equipment for the isolation and purification of nucleic acids; computer hardware and software systems for in vitro diagnostic or scientific research use, namely, electronic systems comprising fluid handlers, plate readers, vial readers, bar code reader, control software, designed for isolation and purification of nucleic acids, set up reaction mixes for polymerase chain reaction (PCR) and PCR thermal cyclers | ACTIVE | — |
| 042 | Scientific research; scientific and technological services, namely, technical research and scientific research in the field of molecular biology; development of computer hardware and software; consultancy services for scientific purposes, namely, consulting in the fields of biotechnology, laboratory testing, and diagnostics; technological laboratory consultancy services, namely, consulting in the field of laboratory testing, scientific laboratories, and medical laboratories; clinical laboratory services, namely, conducting clinical trials for others; medical laboratory services; medical research; biochemical research and development | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by altona Diagnostics GmbH
- Other trademarks owned by altona Diagnostics GmbH
- Other trademarks owned by altona Diagnostics GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named ALTONA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 28, 2026 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Sep 28, 2026 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Sep 21, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Aug 11, 2026 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Aug 11, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jan 27, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 19, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 2, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 2, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 11, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 11, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 26, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 26, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 22, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 6, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 6, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 6, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 20, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 20, 2020 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Apr 20, 2020 | EXPR | EX PARTE APPEAL-REFUSAL REVERSED | — |
| Feb 6, 2020 | RBFT | REPLY BRIEF FILED - CHECK TTAB FILES | — |
| Jan 16, 2020 | GNSN | NOTIFICATION OF EXAMINERS STATEMENT E-MAILED | — |
| Jan 16, 2020 | GNES | EXAMINERS STATEMENT E-MAILED | — |
| Jan 16, 2020 | CNES | EXAMINERS STATEMENT - COMPLETED | — |
| Nov 20, 2019 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Sep 16, 2019 | GEA1 | NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED | — |
| Sep 16, 2019 | GECD | ACTION DENYING REQ FOR RECON E-MAILED | — |
| Sep 16, 2019 | CNCF | ACTION CONTINUING FINAL - COMPLETED | — |
| Sep 10, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 10, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 4, 2019 | ALIE | ASSIGNED TO LIE | — |
| Aug 28, 2019 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Aug 28, 2019 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Aug 28, 2019 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Aug 28, 2019 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| May 17, 2019 | CORN | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Apr 26, 2019 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Mar 1, 2019 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 28, 2019 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 12, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 11, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 11, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 25, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 9, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 9, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 31, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 27, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 26, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 25, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 25, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 24, 2018 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Jul 19, 2018 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |